Products

What will AGI do for Amiphenazole?

This classification denotes a cns stimulant with the molecular formula C9H9N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7ZJ8PWY0XD, chemically known as 2,4-thiazolediamine, 5-phenyl- but generally known as amiphenazole, which bears US NIH Compound Identifier 10275. Amiphenazole most often comes in base and hydrochloride forms. European Medicines Agency schedules Amiphenazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05453MIG. The term AMIPHENAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). AMIPHENAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amiphenazole under HS 29341000 and SITC 51579. As of Q4 2014, AMIPHENAZOLE remains the US FDA Preferred Term for this commodity. Amiphenazole bears US NLM identifiers UMLS ID C0051684 and NCI Concept Code C74238. SMILES: S1C(C2CCCCC2)C(NC1N)N.

How AGI delivers it

Four ways AGI delivers for Amiphenazole

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amiphenazole, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amiphenazole, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amiphenazole connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Loss On Dryingmodel
  • Melting Pointmodel
  • Melting Point Rangemodel
  • Moisture Contentmodel
  • Residual Solventmodel